Solventum (SOLV) Other Non-Current Liabilities (2023 - 2026)
Solventum's (SOLV) quarterly Other Non-Current Liabilities came in at $478.0 million in Q1 2026, up 71.33% YoY from $279.0 million in Q1 2025, and down 12.61% on a QoQ basis from $547.0 million in Q4 2025.
Solventum (SOLV) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends
Solventum (SOLV) has 4 years of Other Non-Current Liabilities data on file, last reported at $478.0 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 71.33% year-over-year to $478.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $478.0 million (up 71.33% YoY) and the FY2025 annual result came in at $547.0 million, up 33.41% from the prior year.
- Other Non-Current Liabilities declined to $478.0 million in Q1 2026, from $547.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $547.0 million in Q4 2025 to a low of $152.0 million in Q4 2023.
- A 4-year average of $345.5 million and a median of $338.0 million in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Other Non-Current Liabilities surged 169.74% — and 2025, when it gained 21.64%.
- Tracing SOLV's Other Non-Current Liabilities over 4 years: stood at $152.0 million in 2023, then surged by 169.74% to $410.0 million in 2024, then surged by 33.41% to $547.0 million in 2025, then retreated by 12.61% to $478.0 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $478.0 million (Q1 2026), $547.0 million (Q4 2025), and $437.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.25 Bn | 129.03 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.47 Bn | 51.61 Bn | 2.32 Bn |
| 3 | Alcon | 35.69 Bn | 34.34 Bn | 1.68 Bn |
| 4 | Resmed | 33.67 Bn | 32.20 Bn | 861.22 Mn |
| 5 | Medline | 29.17 Bn | 26.49 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.06 Bn | 24.62 Bn | 329.20 Mn |
| 7 | Solventum | 15.36 Bn | 14.95 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Align Technology | 11.52 Bn | 10.42 Bn | 757.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 486.00 Mn |
| Mar 31, 2026 | 478.00 Mn |
| Dec 31, 2025 | 547.00 Mn |
| Sep 30, 2025 | 437.00 Mn |
| Jun 30, 2025 | 371.00 Mn |
| Mar 31, 2025 | 279.00 Mn |
| Dec 31, 2024 | 410.00 Mn |
| Sep 30, 2024 | 305.00 Mn |
| Jun 30, 2024 | 305.00 Mn |
| Mar 31, 2024 | 171.00 Mn |
| Dec 31, 2023 | 152.00 Mn |